Filing metadata

Accession number
0001213900-22-072518
Form type
Form 3/A
Filer
Acrivon Therapeutics, Inc.
CIK
CIK 1781174
Filed
Nov 14, 2022
Reporting period
Nov 09, 2022
Description
Initial ownership

Explore SEC Filings Hub